FPMI (FluoroPharma Medical) Cyclically Adjusted Book per Share: $0.00 (As of Dec. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is FluoroPharma Medical Cyclically Adjusted Book per Share?

FluoroPharma Medical FPMI Cyclically Adjusted Book per Share is $0.00 as of Dec. 2016.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

FluoroPharma Medical's adjusted book value per share for the three months ended in Dec. 2016 was $-0.299. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $0.00 for the trailing ten years ended in Dec. 2016.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-08-02), FluoroPharma Medical's current stock price is $0.0002. FluoroPharma Medical's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2016 was $0.00. FluoroPharma Medical's Cyclically Adjusted PB Ratio of today is .


FluoroPharma Medical  (OTCPK:FPMI) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


FluoroPharma Medical Cyclically Adjusted Book per Share Related Terms


FluoroPharma Medical Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for FluoroPharma Medical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FluoroPharma Medical Cyclically Adjusted Book per Share Chart

FluoroPharma Medical Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FluoroPharma Medical Quarterly Data
Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

FPMI vs HSTC, OBMPD, GOVX: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, FluoroPharma Medical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FluoroPharma Medical Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FluoroPharma Medical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where FluoroPharma Medical's Cyclically Adjusted PB Ratio falls into.



FluoroPharma Medical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, FluoroPharma Medical's adjusted Book Value per Share data for the three months ended in Dec. 2016 was:

Adj_Book= Book Value per Share /CPI of Dec. 2016 (Change)*Current CPI (Dec. 2016)
=-0.299/241.4320*241.4320
=-0.299

Current CPI (Dec. 2016) = 241.4320.

FluoroPharma Medical Quarterly Data

Book Value per Share CPI Adj_Book
200703 0.000 205.352 0.000
200706 0.000 208.352 0.000
200709 0.000 208.490 0.000
200712 -0.001 210.036 -0.001
200803 -0.002 213.528 -0.002
200806 -0.002 218.815 -0.002
200809 -0.002 218.783 -0.002
200812 -0.003 210.228 -0.003
200903 -0.003 212.709 -0.003
200906 -0.004 215.693 -0.004
200909 -0.004 215.969 -0.004
200912 -0.004 215.949 -0.004
201003 -0.004 217.631 -0.004
201006 -0.005 217.965 -0.006
201009 -0.005 218.439 -0.006
201012 -0.174 219.179 -0.192
201103 -0.002 223.467 -0.002
201106 0.136 225.722 0.145
201109 0.137 226.889 0.146
201112 0.142 225.672 0.152
201203 0.114 229.392 0.120
201206 0.081 229.478 0.085
201209 0.044 231.407 0.046
201212 0.057 229.601 0.060
201303 0.025 232.773 0.026
201306 -0.011 233.504 -0.011
201309 0.032 234.149 0.033
201312 -0.041 233.049 -0.042
201403 -0.078 236.293 -0.080
201406 -0.132 238.343 -0.134
201409 -0.168 238.031 -0.170
201412 -0.165 234.812 -0.170
201503 -0.185 236.119 -0.189
201506 -0.234 238.638 -0.237
201509 -0.228 237.945 -0.231
201512 -0.239 236.525 -0.244
201603 -0.285 238.132 -0.289
201606 -0.303 241.018 -0.304
201609 -0.293 241.428 -0.293
201612 -0.299 241.432 -0.299

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $0.00 mean?
FluoroPharma Medical (FPMI) has a Cyclically Adjusted Book per Share of $0.00 as of Dec. 2016. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on FluoroPharma Medical and its competitors.
Is FluoroPharma Medical's Cyclically Adjusted Book per Share too high?
FluoroPharma Medical's current Cyclically Adjusted Book per Share is $0.00.
How does FluoroPharma Medical's Cyclically Adjusted Book per Share compare to HSTC and OBMPD?
FluoroPharma Medical's Cyclically Adjusted Book per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on FluoroPharma Medical and its competitors. FluoroPharma Medical's current Cyclically Adjusted Book per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FluoroPharma Medical stock overvalued right now?
FluoroPharma Medical (FPMI) has a current Cyclically Adjusted Book per Share of $0.00. The current Cyclically Adjusted Book per Share is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For FluoroPharma Medical (FPMI), the current Cyclically Adjusted Book per Share is $0.00 as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

FluoroPharma Medical Business Description

Address 701 South Carson Street, Suite 200, Carson City, NV, USA, 89701
FluoroPharma Medical Inc is a us-based biopharmaceutical company. It specializes in developing and commercializing molecular imaging pharmaceuticals with initial applications in the area of cardiology. The company focuses on the development of novel cardiovascular imaging agents which detect and assess acute and chronic forms of coronary artery disease (CAD). The company's clinical-stage molecular imaging pharmaceutical product candidates are 18-F TPP (BFPET) and 18-F FCPHA (CardioPET). The 18-F TPP is designed for use in stress-testing for patients with proven CAD whereas 18-F FCPHA is a molecular imaging agent which is designed to assess myocardial blood flow and metabolism in patients with CAD. The company operates in a single segment being Biopharmaceutical research and development.